Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Alcidion Group Limited ( (AU:ALC) ) has provided an announcement.
Alcidion Group Limited announced the release of its Q1 FY26 Quarterly Cash Flow Report on 28 October 2025, accompanied by a live investor webcast featuring discussions on the quarter’s operational and commercial highlights. This announcement underscores Alcidion’s commitment to transparency and engagement with stakeholders, potentially influencing investor confidence and market positioning.
The most recent analyst rating on (AU:ALC) stock is a Buy with a A$0.13 price target. To see the full list of analyst forecasts on Alcidion Group Limited stock, see the AU:ALC Stock Forecast page.
More about Alcidion Group Limited
Alcidion Group Limited is a company focused on transforming healthcare through innovative technology solutions that enhance patient care efficiency and quality. Their flagship product, Miya Precision, offers a suite of software products and services that aggregate information, support interoperability, and provide clinical decision support. Alcidion has expanded its presence in the UK, Australia, and New Zealand, serving over 400 hospitals and 87 healthcare organizations, with plans for further geographical expansion.
Average Trading Volume: 852,985
Technical Sentiment Signal: Buy
Current Market Cap: A$128.9M
Learn more about ALC stock on TipRanks’ Stock Analysis page.